MacroGenics | MGNX - Stock


MacroGenics reported $8.75M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
AbbVie USD 4.95B 13M Dec/2025
Amgen USD 6.22B 121M Dec/2025
AstraZeneca USD 6.59B 126M Sep/2025
Biogen USD 2.17B 41.3M Dec/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Daiichi Sankyo JPY 608.55B 93.64B Sep/2025
Eli Lilly USD 13.74B 1.56B Dec/2025
Genmab DKK 13M 1000K Jun/2025
Geron USD 116.64M 21.21M Dec/2025
Gilead Sciences USD 1.78B 40M Sep/2025
J&J USD 14.19B 45M Dec/2025
Karyopharm Therapeutics USD 3.97M 1.03M Sep/2025
MacroGenics USD 8.75M 530K Sep/2025
Merck USD 6.44B 157M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
Puma Biotechnology USD 9.48M 885K Sep/2025
Regeneron Pharmaceuticals USD 3.2B 53.6M Dec/2025
Roche Holding CHF 7.6B 9M Jun/2025